LifeSignals UbiqVue 2A Monitoring System Earns FDA Clearance
LifeSignals’ UbiqVue 2A Multiparameter System wireless patient monitoring wearable has received FDA Class II 510(k) clearance.
LifeSignals’ UbiqVue 2A Multiparameter System wireless patient monitoring wearable has received FDA Class II 510(k) clearance.
Masimo has nabbed FDA 510(k) clearance for its W1 medical watch, allowing both over-the-counter and prescription use, enabling continuous monitoring of oxygen saturation and pulse rate for adults in various healthcare settings, including hospitals, clinics, long-term care facilities, and home use.
Honeywell developed a real-time health monitoring system, which captures and records patients' vital signs both in the hospital and remotely.
LifeSignals’ UbiqVue 2A Multiparameter System wireless patient monitoring wearable has received FDA Class II 510(k) clearance.
iSono Health announced U.S. FDA clearance of the company’s compact automated whole breast ultrasound system featuring a wearable accessory.
Read MoreRhaeos announced the issuance of U.S. patents that cover flexible, wearable sensors for non-invasive monitoring of subdermal fluid flow.
Read MoreAktiia—a provider of continuous blood pressure monitoring tech—is bringing its 24/7 Blood Pressure Monitor to the United States.
Read MoreResearchers have shown how electricity is transported in printed 2D materials, which may pave the way for design of flexible devices in healthcare.
Read MoreThe updated Cardiac Insight Cardea SOLO ECG System offers a new option for HL7 interface, streamlining electronic data transfer between healthcare clinics.
Read MoreThe radio waves that permeate the environment are not just signals of energy consumed but are also sources of energy themselves. An international team of researchers has developed a way to harvest energy from radio waves to power wearable devices.
Read MoreSheldon Moberg joins Bexson as senior VP, drug delivery, where he'll lead the development of proprietary devices that can make controlled substances and other therapies more accessible.